Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
From rural communities to busy households, virtual visits remove barriers such as travel time, scheduling conflicts, and long wait periods
Aleniglipron showed 11.3% placebo-adjusted weight loss at 120 mg in the Phase 2b ACCESS study (36 weeks), with a higher exploratory dose reaching 15.3%
But actual results can vary based on an individual: Talk with your doctor to determine a realistic timeline after factoring in your attributes and risk factors
References Caballero-Flores, G., Pickard, J
Weeks 5 through 8: building therapeutic effects At 4mg weekly, retatrutide begins showing its true character
